ALEC Stock Analysis: Buy, Sell, or Hold?
ALEC - Alector, Inc. Common Stock
$2.41
-0.12 (-4.74%)
▼
5d:
+13.68%
30d:
+12.09%
90d:
+54.49%
HOLD
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 14, 2026
Smart Money Accumulation
ALEC is down 8.8% this week, but smart money is accumulating calls. Top strike: $2.5 2026-04-17 with 1,410 OI. Call ratio: 99% View Scanner →
Strength: 9.3/10
Get Alerted When ALEC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ALEC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ALEC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ALEC is currently trading at $2.41, which is considered extended relative to its 30-day fair value range of $2.04 to $2.35.
Technical Outlook: Technically, ALEC is in a strong uptrend. Immediate support is located at $1.95, while resistance sits at $2.63. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: ALEC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $2.88 (+19.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ALEC is in a strong uptrend. Immediate support is located at $1.95, while resistance sits at $2.63. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: ALEC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $2.88 (+19.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$2.04 -
$2.35
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
55.3%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.7%)
- BULLISH: Trading below Wall St target ($2.88)
Fair Price Analysis
30-Day Fair Range
$2.04 -
$2.35
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$1.95
Resistance Level
$2.64
Current Trend
Strong Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.65
Wall Street Target
$2.88
(+19.5%)
Revenue Growth (YoY)
-88.5%
Earnings Growth (YoY)
-86.3%
Share & Embed Analysis
Last updated: April 05, 2026 2:55 PM ET
Data refreshes hourly during market hours. Next update: 3:55 PM
Data refreshes hourly during market hours. Next update: 3:55 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALEC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Grace Wong-Sarad
SELL
1000 shares
2026-03-10
Grace Wong-Sarad
SELL
4079 shares
2026-02-26
Grace Wong-Sarad
SELL
4753 shares
2025-12-05
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 56 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1018 | 56 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$132 | 58 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 60 HOLD |
